Inhibiting lipogenesis can reduce steatosis without increasing inflammatory and profibrotic response, as seen for example in mice lacking hepatic Diacylglycerol Acyltransferase 2 (DGAT2)51,52. Here, AWAT1 is linked to steatosis.